The molecular mechanisms of how the ratio of linear and circular ANRIL is controlled by the genotype at the locus are currently not resolved and it will be important to determine which gene regulatory elements within the ANRIL gene are disturbed by causal CAD risk SNPs. The gene discussed is CDKN2B-AS1; the disease is coronary artery disorder.